Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Trials|August 2, 2020
muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized controlled trialIng Ni Lu, Spoorthy Kulkarni, Marie Fisk, et al.
ERJ Open Research|March 25, 2025
Dysregulation of lipid mediators in patients with frequent exacerbations of COPDMarie Fisk, Esteban A Gomez, Yuan Sun, et al.
BMJ Open Respiratory Research|June 25, 2026
GOLD 2026 COPD ABE assessment tool to identify individuals at high risk in a UK multicentre COPD cohort (ERICA)Gbenga Adesoye, Alastair Watson, Tengyu Zhao, et al.
Plos One|February 11, 2020
Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational studyJilles M Fermont, Charlotte E Bolton, Marie Fisk, et al.
Age and Ageing|September 7, 2020
Short physical performance battery as a practical tool to assess mortality risk in chronic obstructive pulmonary diseaseJilles M Fermont, Divya Mohan, Marie Fisk, et al.
Hypertension (Dallas, Tex. : 1979)|January 24, 2018
Surrogate Markers of Cardiovascular Risk and Chronic Obstructive Pulmonary Disease: A Large Case-Controlled StudyMarie Fisk, Carmel M McEniery, Nichola Gale, et al.
Plos One|March 23, 2018
The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trialMarie Fisk, Joseph Cheriyan, Divya Mohan, et al.
ERJ Open Research|September 3, 2021
Quantitative <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography to assess pulmonary inflammation in COPDLaurence Vass, Marie Fisk, Joseph Cheriyan, et al.
BMJ Open|December 29, 2020
Cardiovascular risk prediction using physical performance measures in COPD: results from a multicentre observational studyJilles M Fermont, Marie Fisk, Charlotte E Bolton, et al.
Thorax|April 6, 2018
Fibrinogen does not relate to cardiovascular or muscle manifestations in COPD: cross-sectional data from the ERICA studyDivya Mohan, Julia R Forman, Matthew Allinder, et al.
Pageof 4